Bio-Reference Laboratories, Inc. provides clinical laboratory testing, information and related services to physician offices, clinics, hospitals, employers and governmental units.
How accurate is the BioReference antibody test?
One chart that summarizes the accuracy of antibody screening New York is using a test from BioReference with a listed sensitivity of 91.2% and specificity of 97.3% for some of the screenings.
Is BioReference laboratories a public company?
Bio-Reference is the nation’s third largest publicly-traded lab company and had revenue of $832 million for its fiscal year ending October 31, 2014.
Who uses Bio-Reference Laboratories?
With a national footprint and niche market experience, BioReference provides credible and innovative solutions that meet the needs of employers, governmental agencies, educational systems, hospitals and health systems, correctional institutions, sports leagues, travel and leisure industries, and retail markets.
How many locations does Bio-Reference have?
Our Company BioReference is the largest full service specialty laboratory offering a comprehensive list of laboratory services. With specialized divisions, 11 laboratory locations, over 200 Patient Service Centers and more than 4,000 employees nationwide, BioReference is a preferred choice for laboratory personnel.
Is Bio-Reference Labs publicly traded?
Who uses Bio Reference Laboratories?
Does BioReference have an app?
View your BioReference test results in the Apple Health app on iPhone* or CommonHealth app on Android devices. It’s easy to view your laboratory test results in the same place as your other important health information. Learn how to get started today.
Is GeneDx owned by BioReference?
In 2006, BioReference Laboratories acquired GeneDx. Since then, GeneDx has operated as a subsidiary of this parent company under the leadership of Bale (retired in 2016) and Compton (retired in 2013).
What is genegenedx genetic testing?
GeneDx is genetic testing company that was founded in 2000 by two scientists from the National Institutes of Health (NIH), Drs. Sherri Bale and John Compton, who started the company to provide clinical diagnostic services for patients and families with rare and ultra-rare disorders for which no such commercial testing was available at the time.
How long has GeneDx been in business?
For over 20 years, GeneDx has been at the forefront of genetic innovation, pioneering new technologies and gene discovery, enabling great diagnostic accuracy for patients and families.
What is the garage’s relationship with Bioreference?
SOMOS will also leverage The Garage’s health platform through a sublicense with BioReference to integrate providers, patients and population health solutions into a knowledge engine for advanced data analytics and centralized care management.
